Cidofovir dihydrate

CAS : 149394-66-1

Ref. TM-T8736

Informations sur le produit

• Nom: Cidofovir dihydrate
• Synonymes: HPMPC, (S)-HPMPC, GS 0504, ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid dihydrate, Cidofovir hydrate, Phosphonic acid, P-[[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, hydrate (1:2), Phosphonic acid, [[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, dihydrate, Phosphonic acid, [[2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, dihydrate, (S)-, acide {[(1S)-2-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-(hydroxyméthyl)éthoxy]méthyl}phosphonique dihydrate, phosphonic acid, [[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, dihydrate, {[(1S)-2-(4-Amino-2-oxopyrimidin-1(2H)-yl)-1-(hydroxymethyl)ethoxy]methyl}phosphons?uredihydrat, {[(1S)-2-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-(hydroxymethyl)ethoxy]methyl}phosphonic acid dihydrate

Description

Cidofovir dihydrate (HPMPC) is an anti-CMV drug, It can suppress CMV replication by selective inhibition of viral DNA polymerase and therefore prevention of viral replication and transcription. Cidofovir dihydrate is an injectable antiviral medication primarily used as a treatment for cytomegalovirus (CMV) retinitis- an infection of the retina of the eye in people with AIDS

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 315.22
• Formule: C₈H₁₈N₃O₈P
• Degré de pureté: 99.97%
• Couleur/Forme: Solid